What prescription progestin-only pill (POP) can be used as a contraceptive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prescription Progestin-Only Pills (POPs) for Contraception

Progestin-only pills (POPs) are effective prescription contraceptives that can be used when estrogen-containing methods are contraindicated, though they are generally less effective than other progestin-only methods like implants, injections, or IUDs. 1

Available Prescription POPs

  • Norethindrone (Micronor, Nor-QD, Camila, Errin) - 0.35 mg
  • Desogestrel (not available in US) - 0.075 mg
  • Drospirenone (Slynd) - 4 mg in 24/4 regimen

Effectiveness and Mechanism of Action

  • POPs work primarily by:

    • Thickening cervical mucus
    • Thinning the endometrial lining
    • Possibly inhibiting ovulation (varies by formulation) 1
  • Effectiveness rates:

    • Perfect use failure rate: 0.5% 2
    • Typical use failure rate: approximately 5% due to late or missed pills 2
    • Less effective than other progestin-only methods like implants (0.05%), injections (0.3%), or IUDs (0.1-0.2%) 1

Administration Guidelines

  • Traditional POPs (norethindrone):

    • Must be taken at the same time every day, within a 3-hour window 3
    • If a dose is missed by >3 hours:
      • Take one pill as soon as possible
      • Continue taking pills daily at the same time
      • Use backup contraception for 2 consecutive days
      • Consider emergency contraception if unprotected intercourse occurred 3
  • If vomiting or severe diarrhea occurs within 3 hours of taking a pill:

    • Take another pill as soon as possible
    • Continue regular schedule
    • Use backup contraception until 2 days after vomiting/diarrhea resolves 3

Ideal Candidates for POPs

POPs are particularly suitable for:

  • Women with contraindications to estrogen-containing contraceptives 1
  • Women with cardiovascular risk factors or hypertension 1
  • Breastfeeding women 1
  • Perimenopausal women 4
  • Women who prefer an oral contraceptive method but cannot use combined pills 5

Contraindications

POPs should not be used in women with:

  • Current breast cancer
  • Severe cirrhosis
  • Unexplained vaginal bleeding 1

Common Side Effects and Management

  • Irregular bleeding patterns are the most common complaint 6
    • Counseling about variable bleeding patterns improves acceptance and compliance 5
  • Other side effects are generally minimal compared to combined hormonal contraceptives
  • No increased risk of thromboembolism or stroke 1

Clinical Considerations

  • POPs are not typically recommended as first-choice contraceptives for healthy adolescents due to the need for strict adherence to timing 3
  • Women who frequently miss POPs should consider alternative methods less dependent on user compliance (IUD, implant, or injectable) 3
  • Condoms should be used concurrently to provide protection against sexually transmitted infections 1
  • Certain medications may compromise POP effectiveness 1

Follow-up Recommendations

  • No routine follow-up visit is required specifically for POP use 3
  • At routine visits, providers should:
    • Assess satisfaction with the method
    • Evaluate any changes in health status or medications
    • Consider assessing weight changes if the patient is concerned 3

POPs provide an important contraceptive option for women who cannot or prefer not to use estrogen-containing methods, though users must be counseled on the importance of consistent timing and potential irregular bleeding patterns to maximize effectiveness.

References

Guideline

Contraceptive Methods

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Using progestins in clinical practice.

American family physician, 2000

Research

Unscheduled vaginal bleeding with progestin-only contraceptive use.

American journal of obstetrics and gynecology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.